Studies of the Hypothalamus-Pituitary-Adrenocortical System: An Example of Progress in Psychoneuroendocrinology

  • F. Holsboer
  • U. von Bardeleben
  • A. Gerken
Conference paper

Abstract

Psychobiological study of affective disorders has passed through several phases during the last three decades. With the discovery of thymoleptic drugs and our partial understanding of their pharmacological properties, a dominant theme in psychiatric research came to be the pathophysiology underlying depressive illness. Since enhancement of monoamine neurotransmission was found to be a common characteristic of most antidepressants, several attempts were made to test the hypothesis of a defective cerebral monoamine transmission as the prime cause of depression. In this context, neuroendocrinology became an area that was of particular interest to investigators, for several reasons. Basic research has demonstrated that endocrine function is centrally regulated by the same transmitters and receptors that are implicated in the pathophysiology of depressive disorders and their biological treatment. Further, the progress of analytical chemistry has enabled investigators to assay minute hormone quantities in blood, urine, and cerebrospinal fluid. Only recently, numerous neuroendocrine tests of monoamine function in depression have been developed, which encompass studies involving the pituitary-adrenocortical axis, secretion of prolactin, gonadotropins, and release of growth hormone and thyroid-stimulating hormone following probes with variable specificity.

Keywords

Adenoma Serotonin Prolactin Aldosterone Fluoxetine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Amsterdam JD, Winokur A, Abelman E, Lucki I, Rickels K (1983) Cosyntropin (ACTH 1-24) stimulation test in depressed patients and healthy subjects. Am J Psychiatry 140:907–909.PubMedGoogle Scholar
  2. Aldenhoff JB, Gruol DL, Rivier J, Vale W, Siggins GR (1983) Corticotropin-releasing factor decreases postburst hyperpolarizations and excites hippocampal neurons. Science 221:875–877.PubMedCrossRefGoogle Scholar
  3. Andreasen NC, Reich T, Scheftner W, Hirschfeld RMA, Coryell W (1984) Endogenous vs nonendogenous depression: validation through family studies. Clin Neuropharmacol 7, suppl1, 708–709.CrossRefGoogle Scholar
  4. Arana GW, Baldessarini RJ, Ornsteen M (1985) The dexametasone suppression test for diagnosis and prognosis in psychiatry. Commentary and Review. Arch Gen Psychiatry 42:1194–1204.Google Scholar
  5. Arana GW, Workman RJ, Baldessarini RJ (1984) Association between low plasma levels of dexamethasone and elevated levels of cortisol in psychiatric patients given dexamethasone. Am J Psychiatry 141:1619–1620.PubMedGoogle Scholar
  6. Aron DC, Tyrell JB, Fitzgerald PA, Findling JW, Forsham PH (1981) Cushing’s syndrome: problems in diagnosis. Medicine 60:25–35.PubMedCrossRefGoogle Scholar
  7. Asnis GM, Sachar EJ, Halbreich U, Nathan RS, Ostrow L, Halpern FS (1981) Cortisol secretion and dexamethasone response in depression. Am J Psychiatry 138:1218–1221.PubMedGoogle Scholar
  8. Asnis GM, Halbreich U, Rabinovich H, Ryan ND, Sachar EJ, Nelson B, Puig-Antich J, Novacenko H (1985) The Cortisol response to desimipramine in endogenous depressives and normal controls: preliminary findings. Psychiatry Res 14:225–233.PubMedCrossRefGoogle Scholar
  9. Atkinson AB, Chestnutt A, Crothers E, Woods R, Weaver JA, Kennedy L, Sheridan B (1985) Cyclical Cushing’s disease: two distinct rhythms in a patient with a basophil adenoma. J Clin Endocrinol Metab 60:328–332.PubMedCrossRefGoogle Scholar
  10. Axelrod J, Reisine TD (1984) Stress hormones: their interaction and regulation. Science 224:452–459.PubMedCrossRefGoogle Scholar
  11. Baldessarini RJ, Arana GW (1985) Does the dexamethasone suppression test have clinical utility in psychiatry? J Clin Psychiatry 46:25–29.PubMedGoogle Scholar
  12. Ball MJ, Hachinsky V, Fox A, Kirshen AJ, Fisman M, Blume W, Kral VA, Fox H, Mersky H (1985) A new definition of Alzheimer’s disease: a hippocampal dementia. Lancet 1:14–16.PubMedCrossRefGoogle Scholar
  13. Bardeleben, von U, Holsboer F, Stalla GK, Müller OA (1985) Combined administration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects. Life Sciences 37:1613–1618.CrossRefGoogle Scholar
  14. Bardeleben, von U, Steiger A, Gerken A, Holsboer F (1986) Pharmacoendocrine and sleep-EEG characteristics of fluoxetine in normal controls. Brit J Clin Practice (in press).Google Scholar
  15. Barnes RF, Veith RC, Borson S, Verhey H, Raskind MA, Halter HB (1983) High levels of plasma catecholamines in dexamethasone-resistant depressed patients. Am J Psychiatry 140:1623.Google Scholar
  16. Beckmann H, Holzmüller B, Fleckenstein P (1984) Clinical investigations into antidepressive mechanisms II. Dexamethasone suppression test predicts response to nomifensine or amitriptyline. Acta Psychiat Scand 70:342–353.PubMedCrossRefGoogle Scholar
  17. Berger M, Pirke K-M, Doerr P, Krieg J-C, von Zerssen D (1983) Influence of weight loss on the dexamethasone suppression test. Arch Gen Psychiatry 40:585–586.PubMedGoogle Scholar
  18. Berger M, Pirke K-M, Doerr P, Krieg J-C, von Zerssen D (1984) The limited utility of the dexamethasone suppression test for the diagnostic process in psychiatry. Br J Psychiatry 145:372–382.PubMedCrossRefGoogle Scholar
  19. Britton DR, Koob HF, Rivier J, Vale W (1982) Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty. Life Sci 31:363–367.PubMedCrossRefGoogle Scholar
  20. Britton KT, Morgan J, Rivier J, Vale W, Koob GF (1985) Chloridiazepoxide attenuates CRF-induced response suppression in the conflict test. Psychopharmacology 86:170–174.PubMedCrossRefGoogle Scholar
  21. Brown MR, Fisher LA, Spiess J, Rivier C, Rivier J, Vale W (1982) Corticotropin releasing factor: actions on the sympathetic nervous system and metabolism. Endocrinology 111:928–931.PubMedCrossRefGoogle Scholar
  22. Brown WA, Haier RJ, Quails C (1980) Dexamethasone suppression test identifies subtypes of depression which respond to different antidepressants. Lancet I:928–929.Google Scholar
  23. Brown WA, Keitner G, Quails CB, Haier R (1985) The dexamethasone suppression test and pituitary-adrenocortical function. Arch Gen Psychiatry 42:121–123.PubMedGoogle Scholar
  24. Buchsbaum MS, Haier RJ (1978) Biological homogeneity, symptom heterogeneity, and the diagnosis of schizophrenia. Schizophr Bull 4:473–475.PubMedGoogle Scholar
  25. Carr DB, Wool C, Lydiard RB, Fisher J, Gelenberg A, Klerman G (1984) Rate-sensitive inhibition of ACTH release in depression. Am J Psychiatry 141:590–592.PubMedGoogle Scholar
  26. Carroll BJ (1983) Dexamethasone suppression test. In: Hall RCW, Bereford TP (eds) Handbook of psychiatric diagnostic procedures, Spectrum.Google Scholar
  27. Carroll BJ, Curtis GC, Mendels J (1976) Neuroendocrine regulation in depression. I. Limbic system-adrenocortical dysfunction. Arch Gen Psychiatry 33:1039–1044.PubMedGoogle Scholar
  28. Carroll BJ, Greden JF, Haskett R, Feinberg M, Albala AA, Martin FJR, Rubin RT, Heath B, Sharp PT, McLeod WL, McLeod MF (1980) Neurotransmitter studies of neuroendocrine pathology in depression. Acta Psychiat Scand [Suppl 280] 183.Google Scholar
  29. Carroll BJ, Feinberg M, Greden JF, Tarika J, Albala AA, Haskett RF, James N, Kronfol Z, Lohr N, Steiner M, de Vigne JP, Young E (1981) A specific laboratory test for the diagnosis of melancholia. Arch Gen Psychiatry 38:15–22.PubMedGoogle Scholar
  30. Checkley SA (1980) Neuroendocrine tests of monamine function in man: a review of basic theory and its application to the study of depressive illness. Psychol Med 10:35–53.PubMedCrossRefGoogle Scholar
  31. Chrousos GP, Vingerhoeds A, Brandon D, Eil C, Pugeat M, DeVroede M, Loriaux DL, Lipsett MB (1982) Primary cortisol resistance in man. A glucocorticoid receptor-mediated disease. J Clin Invest 69:1261–1269.PubMedCrossRefGoogle Scholar
  32. Cohen SI (1980) Cushing’s syndrome: a psychiatric study of 29 patients. Br J Psychiatry 136:120–124.PubMedCrossRefGoogle Scholar
  33. Coppen A, Abou-Saleh M, Milln P, Metcalfe M, Harwood J, Bailey J (1983) Dexamethasone suppression test in depression and other psychiatric illness. Br J Psychiatry 142:498–504.PubMedCrossRefGoogle Scholar
  34. Crapo L (1979) Cushing’s syndrome: a review of diagnostic tests. Metabolism 28:955–977.PubMedCrossRefGoogle Scholar
  35. Davidson J, Lipper S, Zung WWK, Strickland R, Krishnan R, Mahorney S (1984) Validation of four definitions of melancholia by the dexamethasone suppression test. Am J Psychiatry 141:1220–1223.PubMedGoogle Scholar
  36. Davies AO, Lefkowitz RJ (1980) Agonist-promoted high affinity state of the β-adrenergic receptor in human neutrophils: modulation by corticosteroids. J Clin Endocrinol Metab 53:703–738.CrossRefGoogle Scholar
  37. Davies AO, Lefkowitz RJ (1983a) In vitro desensitization of β-adrenergic receptors in human neutrophils: attenuation by corticosteroids. J Clin Invest 71:565–571.PubMedCrossRefGoogle Scholar
  38. Davies AO, Lefkowitz RJ (1983b) Regulation of β-adrenergic receptors by steroid hormones. Ann Rev Phys 40:119–130.Google Scholar
  39. Davis KL, Davis BM, Mohs RC, Mathe AA, Vale W, Krieger D (1984) CSF corticotropin-releasing factor in neuropsychiatric disease. Presented at the Annual Meeting of the American Psychiatric Association, May 10, Los Angeles.Google Scholar
  40. Dilsaver SC, Kronfol Z, Sackellares JC, Greden JF (1983) Antidepressant withdrawal syndromes: evidence supporting the cholinergic overdrive hypothesis. J Clin Psychopharmacol 3:157–164.PubMedGoogle Scholar
  41. Doerr P, Berger M (1983) Physostigmine-induced escape from dexamethasone suppression in normal adults. Biol Psychiatry 18:261–268.PubMedGoogle Scholar
  42. Dunn JD (1984) Bombesin-evoked increase in plasma corticosterone concentration. IRCS Med Sci 12:837–838.Google Scholar
  43. Edelstein CK, Roy-Burne P, Fawzy FI, Dornfeld L (1983) Effects of weight loss on the dexamethasone suppression test. Am J Psychiatry 140:338–341.PubMedGoogle Scholar
  44. Ehlers CL, Henriksen SJ, Wang M, Rivier H, Vale W, Bloom FE (1983) Corticotropin-releasing factor produces increases in brain excitability and convulsive seizures in rats. Brain Res 278:332–336.PubMedCrossRefGoogle Scholar
  45. Engeland WC, Dallman MF (1975) Compensatory adrenal growth is neurally mediated. Neuroendocrinology 19:352–362.PubMedCrossRefGoogle Scholar
  46. Extein I, Pottash ALC, Gold MS (1981) Relationship of thyrotropin-releasing hormone test and dexamethasone suppression test abnormalities in unipolar depression. Psychiatry Res 4:49–53.PubMedCrossRefGoogle Scholar
  47. Falk WE, Mahnke MW, Poskanzer DC (1979) Lithium prophylaxis of corticotropin-induced psychosis. JAMA 241:1011–1012.PubMedCrossRefGoogle Scholar
  48. Fehm HL, Holl R, Steiner K, Klein E, Voigt KH (1984) Evidence for ACTH-unrelated mechanisms in the regulation of cortisol secretion in man. Klin Wschr 62:19–24.PubMedCrossRefGoogle Scholar
  49. Frantz AG, Rabkin MT (1964) Human growth hormone: clinical measurement, response to hypoglycemia and suppression by corticosteroids. New Engl J Med 271:1375–1377.PubMedCrossRefGoogle Scholar
  50. Fuller RW (1981) Serotonergic stimulation of pituitary-adrenal function in rats. Neuroendocrinology 32:118–127.PubMedCrossRefGoogle Scholar
  51. Ganguly A, Meikle AW, Tyler FH, West CD (1977) Assessment of 11 β-hydroxylase activity with plasma corticosterone, deoxycorticosterone, cortisol and deoxycortisol: role of ACTH and angiotensin. J Clin Endocrinol Metab 44:560–568.PubMedCrossRefGoogle Scholar
  52. Ganong WF (1977) Neurotransmitters involved in ACTH secretion: catecholamines. Ann NY Acad Sci 297:509–517.PubMedCrossRefGoogle Scholar
  53. Gerken A, Holsboer F (1986) Cortisol and corticosterone response after syn-corticotropin in relationship to dexamethasone suppressibility of cortisol. Psychoneuroendocrinology.Google Scholar
  54. Gerken A, Maier W, Holsboer F (1985) Weekly monitoring dexamethasone suppression response in depression: its relationship to change of body weight and psychopathology. Psychoneuroendocrinol 10:261–271.CrossRefGoogle Scholar
  55. Gemer RH, Hare TA (1981) CSF GABA in normal subjects and patients with depression, schizophrenia, mania and anorexia. Am J Psychiatry 138:1098–1101.Google Scholar
  56. Giguere V, Labrie F, Cote J, Coy DH, Sueiras-Diaz J, Schally AV (1982) Stimulation of cyclic AMP accumulation and corticotropin release by synthetic ovine corticotropin-releasing factor in rat anterior pituitary cells: site of glucocorticoid action. Proci Natl Acad Sci 79:3466–3469.CrossRefGoogle Scholar
  57. Gold BI, Bowers MB, Roth RH, Sweeney DW (1980) GABA levels in CSF of patients with psychiatric disorders. Am J Psychiatry 137:362–364.PubMedGoogle Scholar
  58. Gold PW, Chrousos G, Kellner C, Post R, Roy A, Augerinos P, Schulte H, Oldfield E, Loriaux L (1984) Psychiatric implications of basic and clinical studies with corticotropin-releasing factor. Am J Psychiatry 141:619–627.PubMedGoogle Scholar
  59. Greden JF, Albala AA, Haskett RF, James N, Goodman L, Steiner M, Carroll BJ (1980) Normalization of dexamethasone suppression test: a laboratory index of recovery from endogenous depression. Biol Psychiatry 15:449–158.PubMedGoogle Scholar
  60. Greden JF, Gardner R, King D, Grunhaus L, Kronfol Z, Carroll BJ (1983) Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility. Arch Gen Psychiatry 40:493–500.PubMedGoogle Scholar
  61. Guillemin R, Rosenberg B (1955) Humoral hypothalamic control of anterior pituitary: a study with combined tissue cultures. Endocrinology 57:599–607.PubMedCrossRefGoogle Scholar
  62. Hashimoto K, Murakami K, Hattori T, Niimi M, Fujino K, Ota Z (1984) Corticotropin-releasing factor (CRF) like immunoreactivity in the adrenal medulla. Peptides 5:707–711.PubMedCrossRefGoogle Scholar
  63. Holsboer F (1983) Prediction of clinical course by dexamethasone suppression test (DST) response in depressed patients — physiological and clinical construct validity of the DST. Pharmacopsychiatry 16:186–191.CrossRefGoogle Scholar
  64. Holsboer F (1985) Adrenocortical steroid secretion and llβ-steroidhydroxylase activity after pituitary-adrenocortical probes in depression. Psychiatr Med 3:65–78.PubMedGoogle Scholar
  65. Holsboer F, Gerken A (1985) The DST as nondiagnostic laboratory aid to monitor clinical progress in depression. In Burrows G (ed) Clinical and pharmacological studies in psychiatric disorder. John Libbey & Co, London.Google Scholar
  66. Holsboer F, Winter K, Doerr HG, Sippel WG (1982a) Dexamethasone suppression test in female patients with endogenous depression: determination of plasma corticosterone, 11-deoxycorticosterone, 11-deoxycortisol, cortisol and cortisone. Psychoneuroendocrinology 7:329–338.PubMedCrossRefGoogle Scholar
  67. Holsboer F, Doerr HG, Sippell WG (1982b) Dexamethasone suppression of 11-deoxycorticosterone, corticosterone and cortisol in depressed female patients and normal controls. Acta Psychiat Scand 66:18–25.PubMedCrossRefGoogle Scholar
  68. Holsboer F, Liebl R, Hofschuster E (1982c) Repeated dexamethasone suppression test during depressive illness. Normalization of test result compared with clinical improvement. J Affective Dis 4:93–101.CrossRefGoogle Scholar
  69. Holsboer F, Müller OA, Winter K, Doerr HG, Sippell WG (1983a) Effect of serotonin uptake inhibition by zimelidine on hypothalamic-pituitary-adrenal activity. Psychopharmacology 80:85–87.PubMedCrossRefGoogle Scholar
  70. Holsboer F, Doerr HG, Sippell WG (1983b) Increased sensitivity of the dexamethasone suppression test in depressed female patients based on multisteroid analysis. Psychiatry Res 8:49–57.PubMedCrossRefGoogle Scholar
  71. Holsboer F, von Bardeleben U, Gerken A, Stalla GK, Müller OA (1984a) Blunted corticotropin and normal cortisol response to human corticotropin-releasing factor (h-CRF) in depression. New Engl J Med 311:1127.PubMedGoogle Scholar
  72. Holsboer F, Gerken A, Fass V (1984b) The mean 14.00–17.00 h plasma cortisol concentration and its relationship to the 1 mg dexamethasone suppression response in depressives and controls. Acta Psychiat Scand 69:383–390.PubMedCrossRefGoogle Scholar
  73. Holsboer F, Gerken A, Steiger A, Benkert O, Müller OA, Stalla GK (1984c) Corticotropin-releasing factor induced pituitary adrenal responses in depression. Lancet 1:55.PubMedCrossRefGoogle Scholar
  74. Holsboer F, Müller OA, Doerr HG, Sippell WG, Stalla GK, Gerken A, Steiger A, Boll E, Benkert O (1984d) ACTH and multisteroid responses to corticotropin releasing factor in depressive illness: relationship to multisteroid responses after ACTH stimulation and dexamethasone suppression. Psychoneuroendocrinology 9:147–160.PubMedCrossRefGoogle Scholar
  75. Holsboer F, Doerr HG, Gerken A, Müller OA, Sippell WH (1984e) Cortisol, 11-deoxycortisol and ACTH concentrations after dexamethasone in depressed patients and healthy volunteers. Psychiatry Res 11:15–23.PubMedCrossRefGoogle Scholar
  76. Holsboer F, Philipp M, Gerken A (1984f) Dexamethasone suppression test (DST) and weight loss. Psychiatry Res 13:353–354.PubMedCrossRefGoogle Scholar
  77. Holsboer F, Gerken A, Stalla GK, Müller OA (1985a) ACTH, cortisol and corticosterone output after ovine corticotropin-releasing factor challenge during depression and after recovery. Biol Psychiatry 20:276–286.PubMedCrossRefGoogle Scholar
  78. Holsboer F, Gerken A, von Bardeleben U, Grimm W, Stalla GK, Müller OA (1985b) Relationship between pituitary responses to human corticotropin-releasing factor and thyrotropin-releasing hormone in depressives and normal controls. Europ J Pharmacol 110:153–154.CrossRefGoogle Scholar
  79. Holsboer F, Gerken A, von Bardeleben U, Grimm W, Beyer H, Müller OA, Stalla GK (1986a) Human corticotropin-releasing hormone in depression — correlation with thyrotropin secretion following thyrotropin releasing hormone. Biol Psychiatry 21:601–611.PubMedCrossRefGoogle Scholar
  80. Holsboer F, Wiedemann K, Gerken A, Boll E (1986b) The plasma dexamethasone variable in depression — test retest studies and early biophase kinetics. Psychiat Research 13:353–354.CrossRefGoogle Scholar
  81. Holsboer F, Wiedemann K, Boll E (1986c) Shortened dexamethasone half-live time in depressed dexamethasone nonsuppressors. Arch Gen Psychiatry (in press).Google Scholar
  82. Hui KK, Conolly ME, Tashkin DP (1982) Reversal of human leucocytes β-adrenoceptor desensitization by glucocorticoids. Clin Pharmacol Ther 32:566–571.PubMedCrossRefGoogle Scholar
  83. Imura H, Nakai Y, Yoshimi T (1973) Effect of 5-hydroxytryptophan (5-HTP) on growth hormone and ACTH release in man. J Clin Endocrinol Metab 36:204–206.PubMedCrossRefGoogle Scholar
  84. Jimerson DC, Insel TR, Reus VI, Kopin IJ (1983) Increased plasma MHPG in dexamethasone resistant depressed patients. Arch Gen Psychiatry 40:173.PubMedGoogle Scholar
  85. Johnson GF, Hunt G, Kerr K, Caterson I (1984) Dexamethasone suppression test (DST) and plasma dexamethasone levels in depressed patients. Psychiatry Res 13:305–313.PubMedCrossRefGoogle Scholar
  86. Jones MT, Hillhouse EW, Burden J (1976) Effect of various putative neurotransmitters on the secretion of CRH from the rat hypothalamus in vitro — a model of the neurotransmitters involved. J Endocrinol 69:1–10.PubMedCrossRefGoogle Scholar
  87. Kawamura H, Ito A, Oishi T, Yanaga T (1984) Influence of glucocorticoids on brain serotonin metabolism in rats. Endocrinol Jpn 31:595–603.PubMedCrossRefGoogle Scholar
  88. Klerman GL (1974) Unipolar and bipolar depressions. In: Angst J (ed) Classification and prediction of outcome of depression. Stuttgart New York, p 55.Google Scholar
  89. Kopin IJ, Jimerson DC, Markey SP, Ebert MH, Polinsky RJ (1984) Disposition and metabolism of MHPG in humans: application to studies in depression. Pharmacopsychiatry 17:3.PubMedCrossRefGoogle Scholar
  90. Kramer RE, Simpson ER, Waterman MR (1983) Induction of 11 β-hydroxylase by corticotropin in primary cultures of bovine adrenocortical cells. J Biol Chem 258:3000–3005.PubMedGoogle Scholar
  91. Kloet, de ER (1984) Function of steroid receptor systems in the central nervous system. Clin Neuropharmacol 7:272–280.PubMedCrossRefGoogle Scholar
  92. Krieger DT, Amorosa L, Linick F (1975) Cyproheptadine-induced remission of Cushing’s disease. New Engl J Med 293:893–894.PubMedCrossRefGoogle Scholar
  93. Krieger DT, Liotta AS, Suda T, Goodgold A, London E (1979) Human plasma immunoreactive lopotropin and adrenocorticotropin in normal subjects and in patients with pituitary-adrenal disease. J Clin Endocrinol Metab 48:566–571.PubMedCrossRefGoogle Scholar
  94. Koob GF, Swerdlow N, Seeligson M, Eaves M, Sutton R, Rivier J, Vale W (1984) Effects of alpha-flupenthixol and naloxone on CRF-induced locomotor activation. Neuroendocrinology 39:459–464.PubMedCrossRefGoogle Scholar
  95. Laakmann G, Schoen HW, Blaschke D, Wittmann M (1985) Dose dependent growth hormone, prolactin and cortisol stimulation after i.v. administration of desipramine in human subjects. Psychoneuroendocrinol 10:83–93.CrossRefGoogle Scholar
  96. Labrie F, Giguere V, Proulx L, Lefevre G (1984) Interactions between CRF epinephrine vasopressin and glucocorticoids in the control of ACTH secretion. J Steroid Biochem 20:153–160.PubMedCrossRefGoogle Scholar
  97. Lamberts SWJ, Verleun T, Oosterom R, de Jong F, Hackeng WHL (1984) Corticotropin-releasing factor (ovine) and vasopressin exerts a synergistic effect of adrenocorticotropin release in man. J Clin Endocrinol Metab 58:298–303.Google Scholar
  98. Leckman JF, Maas JW (1984) Plasma MHPG: relationship to brain noradrenergic systems and emerging clinical applications. In: Post RM, Ballernger JC (eds) Neurobiology of mood disorders. Williams & Wilkins, Baltimore.Google Scholar
  99. Lee PHK, Chan M-Y (1984) Effects of adrenalectomy and adrenal steroids on the uptake of serotonin in rat platelets. Clin Experim Pharmacol Physiol 11:53–59.CrossRefGoogle Scholar
  100. Loosen PT, Prange AJ jr (1982) Serum thyrotropin response to thyrotropin-releasing hormone in psychiatric patients — a review. Am J Psychiatry 139:405–16.PubMedGoogle Scholar
  101. Loosen PT, Prange AJ jr, Wilson IC (1978) The thyrotropin response to thyrotropin-releasing hormone in psychiatric patients: relation to serum cortisol. Prog Neuropsychopharmacol Biol Psychiatry 2:479–486.Google Scholar
  102. Lowy MT, Reder AT, Antel JP, Meltzer HY (1984) Glucocorticoid resistance in depression: the dexamethasone suppression test and lymphocyte sensitivity to dexamethasone. Am J Psychiatry 141:1365–1370.PubMedGoogle Scholar
  103. Lytras N, Grossman A, Perry L, Tomlin S, Wass JAH, Coy DH, Schally AC, Rees LH, Besser GM (1984) Corticotropin-releasing factor: responses in normal subjects and patients with disorders of the hypothalamus and pituitary. Clin endocrinol 20:71–84.CrossRefGoogle Scholar
  104. Makara GB, Stark E (1974) Effects of gamma-aminobutyric acid (GABA) and GABA-antagonist drugs on ACTH release. Neuroendocrinology 16:178–190.PubMedCrossRefGoogle Scholar
  105. Manier DH, Gillespie DD, Steranka LR, Sulser F (1984) A pivotal role for serotonin (5HT) in the regulation of beta-adrenoceptors by antidepressants: reversibility of the action of parachlorophenylalanine by 5-hydroxytryptopohan. Experientia 40:1223–1226.PubMedCrossRefGoogle Scholar
  106. Meltzer HY, Fang VS (1983) Cortisol determination and the dexamethasone suppression test. Arch Gen Psychiatry 40:501–505.PubMedGoogle Scholar
  107. Meltzer HY, Überkoman-Wiita B, Robertson A, Tricou BJ, Lowy M (1983) Enhanced serum cortisol response to 5-hydroxytryptophan in depression and mania. Life Sci 33:2541–2549.PubMedCrossRefGoogle Scholar
  108. Meltzer HY, Lowy MT, Gromley GJ, Reder AT, Hospelhorn VD, Antel JP (1985) Glucocorticoid receptor abnormalities in depression: relation to the dexamethasone suppression (DST). Paper presented at the XVIth International Congress of the ISPNE, 14-18 April 1985, Kyoto.Google Scholar
  109. Mendelson WB (1982) Studies of human growth hormone secretion in sleep and waking. Int Rev Neurobiol 23:367–389.PubMedCrossRefGoogle Scholar
  110. Merchenthaler I, Hynes MA, Vigh S, Schally AV, Perusz P (1984) Corticotropin-releasing factor (CRF): origin and course of afferent pathways to the median eminence (ME) of the rat hypothalamus. Neuroendocrinology 39:296–306.PubMedCrossRefGoogle Scholar
  111. Mezey E, Reisine TD, Plakovits M, Brownstein MJ, Axelrod J (1983) Direct stimulation ofβ2-adrenergic receptors in rat anterior pituitary induces the release of adrenocorticotropin in vivo. Proc Natl Acad Sci 80:6728–6731.PubMedCrossRefGoogle Scholar
  112. Mezey E, Kiss JZ, Skirboll LR, Goldstein M, Axelrod J (1984) Increase of corticotropin-releasing factor staining in rat paraventricular nucleus neurones by depletion of hypothalamic adrenaline. Nature 310:140–141.PubMedCrossRefGoogle Scholar
  113. Mormede P (1983) The vasopressin receptor antagonist dPTyr (Me) AVP does not prevent stress-induced ACTH and corticosterone release. Nature 302:345–346.PubMedCrossRefGoogle Scholar
  114. Müller OA, Doerr HG, Hagen B, Stalla GK, von Werder K (1982) Corticotropin releasing factor (CRF) stimulation test in normal controls and patients with disturbance of the hypothalamo-pituitary-adrenal axis. Klin Wschr 60:1485–1491.Google Scholar
  115. Nakai Y, Imura H, Yoshimi T (1973) Adrenergic control mchanism for ACTH secretion in man. Acta Endocrin 74:263–270.Google Scholar
  116. Nemeroff CB, Evans DL (1984) Correlation between the dexamethasone suppression test in depressed patients and clinical response. Am J Psychiatry 141:247–249.PubMedGoogle Scholar
  117. Nemeroff CB, Widerlöv E, Bissette G, Walleus H, Karlsson I, Eklund K, Kilts CD, Loosen PT, Vale W (1984) Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 226:1342–1344.PubMedCrossRefGoogle Scholar
  118. Nicoloff JT, Fisher DA, Appleman MD (1979) The role of glucocorticoids in the regulation of thyroid function in man. J Clin Invest 49:1922–1929.CrossRefGoogle Scholar
  119. Ono N, Lumpkin MD, Samson WK, McDonald JK, McCann SM (1984) Intrahypothalamic action of corticotropin-releasing factor (CRF) to inhibit growth hormone and LH release in the rat. Life Sci 35:1117–1123.PubMedCrossRefGoogle Scholar
  120. Orth DN, Jackson RV, DeCherney GS, DeBold CR, Alexander AN, Island DP, Rivier J, Rivier C, Spiess J, Vale W (1983) Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol. J Clin Invest 71:587–595.PubMedCrossRefGoogle Scholar
  121. Ottenweller JE, Meier AH (1982) Adrenal innervation may be an extrapituitary mechanism able to regulate adrenocortical rhythmicity in rats. Endocrinology 111:1334–1338.PubMedCrossRefGoogle Scholar
  122. Pasqualini RQ, Gurevich N (1956) Spontaneous remission in a case of Cushing’s syndrome. J Clin Endocrinol 16:406–411.CrossRefGoogle Scholar
  123. Petraglia F, Faccinetti H, Martignoni E, Nappi G, Volpe A, Genazzani AR (1984) Serotonergic agonists increase plasma levels of β-endorphin and β-lipotropin in humans. J Clin Endocrinol Metab 59:1138–1142.PubMedCrossRefGoogle Scholar
  124. Philipp M, Maier W (1985) Operational diagnosis of endogenous depression. I. Comparison with clinical diagnosis. Pharmacopsychiatry 18:112–113.CrossRefGoogle Scholar
  125. Philipp M, Maier W, Holsboer F (1985) Psychopathological correlates of plasma cortisol after dexamethasone suppression: a polydiagnostic approach. Psychoneuroendocrinology.Google Scholar
  126. Plotsky PM, Bruhn TO, Vale W (1984) Central modulation of immunoreactive corticotropin-releasing factor secretion by arginine vasopressin. Endocrinology 115:1639–1641.PubMedCrossRefGoogle Scholar
  127. Prange AJ, Loosen PT (1984) Findings in affective disorder relevant to the thyroid axis, melanotropin, oxytocin and vasopressin. In: Brown GM, Koslow SH, Reichlin S (eds) Neuroendocrinology on psychiatric disorders. Raven, New York.Google Scholar
  128. Price J, Ward G (1977) Cyproheptadine in bipolar affective illness with cushingoid features. Austr New Zeal J Psychiatry 11:201–202.CrossRefGoogle Scholar
  129. Reisine T, Heisler S, Hook VYH, Axelrod J (1982) Multireceptor-induced release of adrenocorticotropin from anterior pituitary tumor cells. Biochem Biophys Res Comm 108:1251–1257.PubMedCrossRefGoogle Scholar
  130. Reus VI (1984) Diagnosis and treatment in endocrinology and psychiatry: from Cushing’s syndrome to disorders of mood. In: Temoshok L, Zegans L, Van Dyke C (eds) Mind and medicine. Grune Stratton, London.Google Scholar
  131. Reus VI, Miner C (1985) Evidence for physiological effects of hypercortisolemia in psychiatric patients. Psychiatr Res 14:47–56.CrossRefGoogle Scholar
  132. Reus VI, Joseph MS, Dallman WF (1982) ACTH levels after the dexamethasone suppression test in depression. New Engl J Med 306:238–239.PubMedGoogle Scholar
  133. Reus VI, Joseph M-S, Dallman MF (1983) Regulation of ACTH and cortisol in depression. Peptides 4:785–788.PubMedCrossRefGoogle Scholar
  134. Ritchie JC, Carroll BJ, Olton PR, Skively V, Feinberg M (1985) Plasma cortisol determination for the dexamethasone suppression test. Arch Gen Psychiatry 42:493–497.PubMedGoogle Scholar
  135. Rivier C, Vale W (1983) Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin. Nature 305:325–327.PubMedCrossRefGoogle Scholar
  136. Roberts DCS, Bloom FE (1981) Adrenal steroid-induced changes in β-adrenergic receptor binding in rat hippocampus. Europ J Pharmacol 74:37–41.CrossRefGoogle Scholar
  137. Rosenbaum AH, Maruta R, Schatzberg AF, Orsulak PJ, Jiang NS, Coel JO, Schildkraut JJ (1983) Toward a biochemical classification of depressive disorders, VII: Urinary free cortisol and urinary MHPG in depressions. Amer J Psychiatry 140:314–318.Google Scholar
  138. Rubin RT, Mandell AJ (1966) Adrenal cortical activity in pathological emotional states: a review Am J Psychiatry 123:387–400.PubMedGoogle Scholar
  139. Rubin RT, Mandell AJ, Chandall PH (1966) Corticosteroid responses to limbic stimulation in man: localization of stimulus sites. Science 153:767–768.PubMedCrossRefGoogle Scholar
  140. Rubinow DR, Post RM, Savard R, Gold PW (1984) Cortisol hypersecretion and cognitive impairment in depression. Arch Gen Psychiatry 41:279–283.PubMedGoogle Scholar
  141. Saffran M, Schally AV (1955) Release of corticotropin by anterior pituitary tissue in vitro. Can J Biochem Physiol 33:408–415.PubMedCrossRefGoogle Scholar
  142. Schürmeyer TH, Augerinos PC, Gold PW, Gallucci WT, Tomai TP, Cutler GB jr, Loriaux DL, Chrousos GP (1984) Human corticotropin-releasing factor in man: pharmacokinetic properties and dose response of plasma adrenocorticotropin and cortisol secretion. J Clin Endocrinol Metab 59:1103–1108.PubMedCrossRefGoogle Scholar
  143. Scott RS, Espiner EA, Donald RA (1979) Intermittent Cushing’s disease with spontaneous remission. Clin Endocrinol (Oxf) 11:561–566.CrossRefGoogle Scholar
  144. Sherman BM, Schlechte JA, Pfohl BM (1984) Dissociation of plasma cortisol and ACTH responses to dexamethasone in healthy subjects. Hormone Res 20:157–165.PubMedCrossRefGoogle Scholar
  145. Shibahara S, Morimoto Y, Furutani Y, Notake M, Takahashi H, Shimizu S, Horikawa S, Numa S (1983) Isolation and sequence analysis of the human corticotropin-releasing factor precursor gene. EMBO J 2:775–779.PubMedGoogle Scholar
  146. Smith DJ, Kohler PC, Helminiak R, Carroll J (1982) Intermittent Cushing’s syndrome with an empty sella turica. Arch Int Med 142:2185–2187.CrossRefGoogle Scholar
  147. Smythe GA, Grunstein HS, Bradshaw JE, Nicholson MV, Compton PJ (1984) Relationships between brain noradrenergic activity and blood glucose. Nature 308:65.PubMedCrossRefGoogle Scholar
  148. Souza, de ED, van Loon GR (1984) Corticotropin-releasing factor increases the adrenocortical responsiveness to adrenocorticotropin. Experientia 40:1004–1006.PubMedCrossRefGoogle Scholar
  149. Souza, de ED, Perrin MH, Insel TR, Rivier J, Vale WW (1984) Corticotropin-releasing factor receptors in rat forebrain: audioradiographic identification. Science 224:1449–1451.PubMedCrossRefGoogle Scholar
  150. Starkman MN, Schteingart DE (1981) Neuropsychiatrie manifestations of patients with Cushing’s syndrome. Relationship to cortisol and adrenocorticotropin hormone levels. Arch Int Med 141:215–219.CrossRefGoogle Scholar
  151. Starkman MN, Schteingart DE (1983) Cushing’s syndrome: changes in psychiatric symptomatology and hormone levels with treatment. Psychol Med 45:83–95.Google Scholar
  152. Sulser F (1984) Regulation and function of noradrenaline receptor systems in brain. Psychopharmacological aspects. Neuropharmacology 23:255–261.PubMedCrossRefGoogle Scholar
  153. Sutton RE, Koob GF Le Moa M, Rivier J, Vale W (1982) Corticotropin-releasing factor produces behavioral activation in rats. Nature 297:331–333.PubMedCrossRefGoogle Scholar
  154. Swanson LW, Sawchenko PE, Rivier J, Vale WW (1983) Organization of ovine corticotropinreleasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36:165–186.PubMedCrossRefGoogle Scholar
  155. Tilders F, Tatemoto K, Berkenbosch F (1984) The intestinal peptide PHI-27 potentiates the action of corticotropin-releasing factor on ACTH release from rat pituitary fragments in vitro. Endocrinology 115:1633–1635.PubMedCrossRefGoogle Scholar
  156. Vale W, Spiess J, Rivier C, Rivier J (1981) Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropoin and β-endorphin. Science 213:1341–1397.CrossRefGoogle Scholar
  157. Valentino RJ, Foote SL, Aston-Jones G (1983) Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus. Brain Res 270:363–367.PubMedCrossRefGoogle Scholar
  158. Wiedemann K, Holsboer F (1986) Pharmacokinetics of dexamethasone in depressed patients during the dexamethasone suppression test (DST). Acta Endocrinologica 111 (Suppl 274:176–177(1986).Google Scholar
  159. Willner P (1984) The ability of antidepressant drugs to desensitize β-receptors is inversely correlated with the clinical potency. J Affective Dis 7:53–58.CrossRefGoogle Scholar
  160. Wolff SM, Adler RC, Buskirik ER, Thompson RH (1964) A syndrome of periodic hypothalamic discharge. Am J Med 36:956–967.PubMedCrossRefGoogle Scholar
  161. Wolfson B, Manning RW, Davis LG, Arentzen R, Baldino F jr (1985) Colocalization of corticotropin-releasing factor and vasopressin mRNA in neurones after adrenalectomy. Nature 315:59–61.PubMedCrossRefGoogle Scholar
  162. Wurtman RJ, Axelrod J (1965) Adrenaline synthesis: control by the pituitary gland and adrenal glucocorticoids. Science 150:1464–1465.PubMedCrossRefGoogle Scholar
  163. Zondek H, Leszynski HE (1956) Transient Cushing’s syndrome with report of a case. Br Med J 197-200.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • F. Holsboer
    • 1
  • U. von Bardeleben
    • 1
  • A. Gerken
    • 1
  1. 1.Psychiatrische Klinik der Universität MainzMainz 1Germany

Personalised recommendations